The FDA issued “immediately in effect” guidance for manufacturers of Class I and unclassified medical devices on compliance dates for meeting unique device identification requirements. Source: The GMP Letter
Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know. Source: BioSpace
The deal includes a licence to use OXB's LentiVector Enabled technology and access to its industrial-scale manufacturing technology. Source: BioSpace
Teva got a nice shot in the arm after reports that billionaire investor Warren Buffett took a stake in the company. Source: BioSpace
Investors and analysts had been encouraging Gilead to acquire something for a long time, so they were mostly happy when it bought Kite Pharma in September. Source: BioSpace
When David Hung abruptly left Axovant Sciences this week, he walked away with a hefty severance package of $2.26M as well as a discretionary bonus of $300,000, according to a…
Janssen got a little love from the FDA on Wednesday. Source: BioSpace
Vertex has declined to comment, but BioCentury received a copy of the letter the company sent to laboratories explaining. Source: BioSpace
Mr. Cross has held the position of President and COO of GTBP since November 16, 2017. Source: BioSpace
The FDA sent a warning letter to Chinese manufacturer Guangzhou Baiyunshan for failing to follow proper cleaning, validation and storage procedures at its Guangzhou, Guangdong facility. Source: Drug Industry Daily